retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial Guide 2023: Weight Loss, Benefits, Results, Dosage What GLP‑3 Really Is: Retatrutide

GLP-1 medications are often used specifically to promote weight loss, and the metabolic changes accompanying that process can affect bone turnover and lower bone density, says Dr

So activating the glucagon receptor might seem counterproductive for metabolic health

The reproducibility of subjective appetite scores

Favor SGLT2 inhibitors or a GLP-1 receptor agonist over placebo

(30) Additionally, the patient population differed from those in previous studies, as it excluded individuals with high cardiovascular risk

This trial underscores the expanding scope of incretin therapy beyond simple weight management, a trend also visible in the growing body of research on peptides for athletic performance and recovery